Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page
- Check3 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedNew related-topic links for Melanoma and MedlinePlus Genetics appear on the page, and a government funding-status notice for NIH operations has been removed.SummaryDifference0.6%

- Check17 days agoChange DetectedRemoved indexing keywords 'Melanoma' and 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoChange DetectedThe study record content remains consistent across versions, including the Brief Summary, Eligibility Criteria, Design details, and Primary/Secondary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check32 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded MedlinePlus Genetics topic: Melanoma. No deletions observed.SummaryDifference0.2%

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.